A Review on the Carcinogenic Roles of DSCAM-AS1

Soudeh Ghafouri-Fard1, Tayyebeh Khoshbakht2, Mohammad Taheri3

  • 1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Long non-coding RNA DSCAM-AS1 plays a key role in cancer development across multiple types. This review summarizes its oncogenic functions and interactions with microRNAs and signaling pathways.

Area of Science:

  • Molecular Biology
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are crucial in carcinogenesis.
  • DSCAM Antisense RNA 1 (DSCAM-AS1) is an lncRNA initially identified in breast cancer.
  • DSCAM-AS1's oncogenic roles extend beyond breast cancer to other malignancies.

Purpose of the Study:

  • To summarize the findings on the oncogenic role of DSCAM-AS1.
  • To consolidate knowledge on DSCAM-AS1's involvement in various cancers.
  • To highlight interactions of DSCAM-AS1 with microRNAs and signaling pathways.

Main Methods:

  • Literature review and summarization of existing studies.
  • Analysis of reported experimental data on DSCAM-AS1 function.
  • Compilation of identified molecular interactions.

Main Results:

  • DSCAM-AS1 is implicated in the carcinogenesis of breast, lung, colorectal, osteosarcoma, liver, melanoma, and cervical cancers.
  • DSCAM-AS1 interacts with numerous microRNAs, including miR-577, miR-122-5p, and miR-204-5p.
  • DSCAM-AS1 influences the Wnt/β-catenin signaling pathway.

Conclusions:

  • DSCAM-AS1 is a significant oncogenic lncRNA with diverse roles in cancer.
  • Understanding DSCAM-AS1's molecular interactions is vital for cancer research.
  • DSCAM-AS1 presents a potential therapeutic target in multiple cancer types.